entertainment -WSS

entertainment

author：Wikipedia 2025-10-02 21:05:09 - browse：5

A gene therapy study, halted when four children with a rare neuromuscular disorder died after treatment, showed enough promise to merit finding a path forward, according to the medicine’s manufacturer.

The treatment, made by the Japanese pharmaceutical company Astellas, led to severe and fatal liver problems for four of the 24 treated children with X-linked myotubular myopathy, or XLMTM, a genetic disease that severely degrades muscle function and kills most patients before the age of 10. Three died in 2020; the fourth died a year later.

In an analysis of its clinical trial, published in Lancet Neurology on Wednesday, Astellas observed dramatic benefits in the study’s surviving patients and a potential explanation for the deaths that derailed the trial. The hope, for Astellas and for families affected by XLMTM, is that the company can find a safe way to proceed and convince the Food and Drug Administration to allow it to resume development.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Watch the official trailer for 'Ahsoka' series

knowledge

WSS

Virtual care provider acquires bankrupt Pear's prescription apps

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Companies helping big Covid

Vermont grapples with historic flooding as more rainstorms head for Northeast

Va. Republicans encourage early voting, a target of Trump's, ahead of fall elections

Grail spinoff by Illumina should end disastrous merger attempt

hotspot

entertainment

focus

Tori Bowie and the unacceptable rates of Black maternal death

The debate over Covid

The cancer drug shortage isn’t new — and neither are the solutions

EU fines Illumina $475 million over Grail acquisition

Hepatitis C has a cure — but many Americans still lack access to it

Christmas in the PICU brings some surprising joy

In Memoriam: Notable people who died in 2023

Grail spinoff by Illumina should end disastrous merger attempt

Sports medicine is finally prioritizing gender equality

Christmas in the PICU brings some surprising joy

hotspot

CRISPR gene editing developments we’re watching in 2024

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Virtual care provider acquires bankrupt Pear's prescription apps

A Greenpeace activist is fined for crash

The debate over Covid

Digital health funding stays low as a new reality sets in

Wikipedia

Wikipedia

knowledge

Wikipedia